Assisted reproductive technologies (ART) have become an integral component of infertility care worldwide. Alongside their widespread clinical use, growing ...

Oh, sure, I can “code.” That is, I can flail my way through a block of (relatively simple) pseudocode and follow the flow. I ...

Software developers have spent the past two years watching AI coding tools evolve from advanced autocomplete into something that can, in some cases, build entire applications from a text prompt. Tools ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Real-world and clinical trial data underscore long-term safety and effectiveness in pediatric and adult NPC patients ...

The funding comes from the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program at ARPA-H, an agency within the U.S. Department of Health and Human Services. The PRINT ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

The "Dream High" charitable surgery program will return to Hong Ngoc General Hospital in March 2026, in collaboration with ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Grand Forks high school students are getting career experience and mentorship through an intern program and talent ...

Recent news coverage around the closure of the Parents and Grandparents Program (PGP) in 2026 does not tell the full story.

By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT In the wake of the December analyst day, Ligand Pharmaceuticals, Inc.’s (NASDAQ:LGND) partners have seen meaningful activity ...